Yet because of their incredibly weak IP protections many drug companies are reluctant to sell there. Hundreds of medicines simply aren't available despite being released a decade earlier and Indians in need have to pay European prices for access to modern pharmaceuticals. It's entirely destroyed any chance for local r&d too.
It's not a net benefit.
I'm all for sticking it to the Man and especially criticising big pharma but suggest reconsidering your viewpoint here.